Intangible Assets

The strategic importance of intangible assets has risen dramatically over the past four decades. In 1975, tangible assets such as property, plant, and equipment accounted for approximately 83% of the market value of S&P 500 companies. By 2020, that figure had inverted: intangible assets represented roughly 90% of S&P 500 market value according to Ocean Tomo's annual study. This transformation reflects the shift from industrial to knowledge-based economies, where competitive advantage increasingly derives from what organizations know, own intellectually, and can do rather than from physical resources they control.

Intangible assets encompass a broad range of resources. Intellectual property, including patents, copyrights, trademarks, and trade secrets, provides legal protection for innovations and creative works. Brand equity represents the accumulated value of customer recognition, trust, and loyalty associated with a company's name and products. Proprietary data and algorithms have become critical assets in the digital economy. Organizational capabilities, including specialized processes, talent networks, and institutional knowledge, constitute intangible resources that are difficult for competitors to observe and replicate. Customer relationships and contracts also represent significant intangible value.

The valuation and management of intangible assets present distinctive challenges. Unlike physical assets, intangibles are often difficult to value precisely, cannot be easily separated from the organization that created them, and may not appear on traditional balance sheets. Accounting standards require many internally generated intangibles, such as brand value and organizational knowledge, to be expensed rather than capitalized, creating a systematic gap between book value and market value for intangible-intensive firms. This disconnect has prompted ongoing debate among investors, regulators, and accounting standard-setters about how to improve financial reporting for the intangible economy.

The pharmaceutical industry illustrates the strategic centrality of intangible assets. A drug company's most valuable assets are its patents, clinical trial data, and R&D pipeline rather than its manufacturing facilities. Pfizer's mRNA technology platform, which enabled rapid development of its COVID-19 vaccine, represents an intangible asset with enormous strategic and economic value. Similarly, technology companies like Microsoft derive most of their competitive advantage from software intellectual property, cloud infrastructure know-how, and customer ecosystem lock-in rather than from any physical assets.

Jonathan Haskel and Stian Westlake's 2018 book 'Capitalism without Capital' identified four distinctive economic properties of intangible assets that shape their strategic implications: scalability (they can be used simultaneously in multiple contexts without being depleted), sunk costs (investment is often irrecoverable if the venture fails), spillovers (benefits may leak to competitors), and synergies (intangibles are often more valuable in combination than in isolation). These properties mean that strategies for building, protecting, and leveraging intangible assets differ fundamentally from strategies for managing physical assets.